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Cornell University 2017 
 
Most eukaryotic genes have their protein coding sequences interrupted by non-
coding introns, which must be removed from nascent pre-mRNAs by the spliceosome 
to generate a translatable mRNA. The past few decades have been marked by a 
significant increase in our appreciation for the central role that splicing plays in 
regulating eukaryotic gene expression. Nevertheless, the mechanisms by which this 
process is normally regulated, and can be mis-regulated with pathological 
consequences, remain poorly understood. 
Next-generation sequencing (NGS) technologies have had a profound effect on 
our understanding of pre-mRNA splicing. Yet in spite of the power presented by this 
approach, it is less widely appreciated that the depth of sequencing necessary to 
quantitatively detect many splicing isoforms is significantly higher than most RNA-
Seq experiments generate. Here I present the development and implementation of a 
novel sequencing method designed to harness the quantitative power of sequencing 
while focusing it on user-selected splice junctions of interest through targeting for 
introns at the reverse transcription step. This approach can dramatically enrich the 
fraction of reads in each sequencing experiment that are informative about splicing 
status, and in doing so enable a significant increase in the precision with which 
changes in splicing can be detected, all while decreasing experimental costs.  
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Chapter 1: Introduction 
1.1: Introduction to splicing 
All life rely on genetic information found in genes to properly function. The 
central dogma of biology, which explains the transfer of genetic information, states that 
in order to carry out a gene’s designated cellular role, genetic information flows from 
DNA to RNA in a process called transcription and subsequently to proteins in a 
processed called translation (Yung and Primm 2015, Figure 1.1).  
 
Figure 1.1: The central dogma of biology. Arrows represent flow of genetic 
information 
 
Genes are present in the genome in the form of DNA nucleotides that are used 
as a template to transcribe RNA transcripts. Subsequently the RNA can act as a 
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translation template to create the protein product for that gene. This flow of genetic 
information is collectively coined gene expression and must be carefully regulated by 
the organism to ensure the proper amount of protein products are synthesized (Rockman 
and Kruglyak 2006). There are many ways in which gene expression can be regulated, 
and one such example is through a process called splicing (Long and Caceres 2009). 
Many eukaryotic organisms contain non-coding intervening sequences (introns) in their 
genes in addition to coding sequences (exons). In general, intervening sequences do not 
contain useful information for protein synthesis in translation and must be removed for 
the pre-messenger RNAs (pre-mRNAs) to be altered into a mature messenger RNA 
(mRNA), the substrate for translation (William Roy and Gilbert 2006). This process of 
intron removal and exon joining is called splicing, an important mechanism for 
regulating gene expression (Hughes 2006).   
 
1.2: The spliceosome is the core splicing machinery 
Splicing at its core is the combination of two sequential transesterification 
reactions that first removes the intron and subsequently joins the exons (Chanfreau and 
Jacquier 1996). As an example, the simplest form of splicing, in which two exons are 
separated by a single intron is illustrated in (Figure 1.2). The 5’ and 3’ end boundaries 
of the intron are termed the 5’ splice site (5’ SS) and the 3’ splice site (3’ SS), 
respectively.  
 
 - 11 - 
 
Figure 1.2: Simple representation of splicing. Blue boxes represent exons, black line 
represents the intron. Locations of the 5’ and 3’ splice sites are labeled. 
 
Splicing is often more complex than the simple removal of an intron. For 
example, a gene can retain the intron in the mRNA instead of splicing it out in a process 
called intron retention (Jung et al. 2015). Alternatively, the intron can be removed, but 
with a different 5’ SS and/or 3’ SS than the canonical one. Additionally, in genes where 
2 or more introns exist, different exons can be skipped when splicing occurs, resulting 
in very different mRNAs from the canonically spliced transcript (Figure 1.3). These 
different forms of splicing are collectively called alternative splicing (Chen and Manley 
2009) and add further control in regulating gene expression by controlling the protein 
product formed from a gene.  
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Figure 1.3: Examples of alternative splicing. Lines above transcript signifies 
positions where exons are joined. 
 
Although the underlying transesterifications behind splicing are rather simple 
chemical reactions on their own, to ensure high fidelity and efficiency, the molecular 
machinery required in this process, the spliceosome, is massive and complex (Matera 
and Wang 2014). The conserved eukaryotic spliceosomal machinery is composed of 
five small nuclear ribonucleoproteins (snRNPs) named U1, U2, U4, U5 and U6. Each 
of the snRNPs contain a unique small nuclear RNA (snRNA) along with a set of Sm or 
Lsm proteins and a varying number of other particle specific proteins (Will and 
Luhrmann 2011). The massive complex does not have pre-formed active sites, but rather 
must be assembled in a stepwise fashion onto each target transcript (Chiou and Lynch 
2014). Assembly begins with binding of U1 snRNP at the 5’ splice site (5’ SS) of the 
pre-mRNA. The U2 snRNP subsequently binds to the branch point (BP) of the pre-
mRNA, forming the A complex, followed by the addition of the pre-assembled U4/6-
U5 tri-snRNP, forming the pre-catalytic B complex. Upon the U4/6-U5 tri-snRNP 
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binding, major RNA-RNA and RNA-protein rearrangements occur and U1 and U4 
snRNPs are destabilized and the spliceosome is activated for catalysis, giving rise to the 
Bact complex. (Staley and Guthrie 1998). Catalytic activation by the DEAH-box RNA 
helicase Prp2 generates the B* complex which catalyzes the first of the two steps of 
splicing, resulting in the formation of the C complex. The C complex then completes 
the second step of splicing, resulting in the formation of an excised intron lariat while 
joining the exons in question. Spliceosomal components are then recycled to be used on 
another intron (Will and Luhrmann 2011, Figure 1.4). 
 
Figure 1.4: Illustration of the detailed process of spliceosome assembly and steps of 
splicing. Circles represent the snRNPs. Adapted from Will and Luhrmann 2011. 
 
At first glance, it is apparent that U1 and U2 snRNPs find their respective targets, 
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the 5’ SS and BP respectively, through complementary base pairing between their 
snRNAs and the sequences of the target sites. However, the complementarity alone does 
not explain the high observed fidelity of splicing (Kim et al. 2017). Some mutations in 
the 5’SS can be suppressed by matching mutation in the corresponding snRNA, but 
other mutations cannot, suggesting base pairing between U1 and the 5’SS is necessary 
but not sufficient for the splicing of mRNA precursors (Zhuang and Weiner 1986). The 
consensus sequence degeneracy also varies greatly between organisms. For example, 
even though the consensus sequence at the 5’SS is quite conserved in yeast, it is very 
degenerate in humans, where only a GT (GU in RNA) is absolutely required (Figure 
1.5, Carmel 2004). This degeneracy brings up interesting questions of how fidelity is 
maintained and cryptic 5’SSs are avoided, as many non-splice site GUs appear through 
genes by random chance. The currently accepted hypothesis in the field is that the 
degeneracy allows for additional opportunities for extra factors to regulate splicing, an 
ongoing topic of research in the field (Crotti and Horowitz 2009).  
 
Figure 1.5: Human 5’ splice sites are more degenerate than budding yeast. 
“WebLogo” (Crooks et al. 2004) representation of 5’ splice sites for humans and 
budding yeast shown. U1 snRNA sequence shown in middle. Letter height represents 
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frequency of basepair occurrences at the indicated location. Dotted line represent the 
boundary between exon and intron. 
 
A simplification of the complex splicing process can be reduced to just the two 
core chemical steps, both of which are trans-esterifications. To illustrate this, consider 
a simple single intron containing transcript. The first chemical step happens when the 
2’ hydroxyl group of the conserved adenosine residue at the branchpoint attacks the 
conserved guanine of the 5’ splice site (Maschhoff and Padgett 1993). This results in 
the formation of an unusual 2’ - 5’ phosphodiester RNA lariat structure between the 
branchpoint adenosine and the 5’ splice site guanine, and cleaves the 5’ exon1-intron 
junction, leaving exon 1 with a free 3’ hydroxyl, and exon 2 connected to the intron in 
what is termed a lariat intermediate. The second chemical step (Horowitz 2012) happens 
when the 3’ hydroxyl of exon1 attacks the scissile phosphodiester bond of the conserved 
guanine at the 3’ splice site at the end of the intron (Podar, Perlman, and Padgett 1998). 
This results in the joining of exon 1 and exon 2, and the release of the lariat intron 
structure (Figure 1.6). It is important in studying splicing that the intermediate products 
can be monitored to evaluate its efficiency and fidelity (Coombes and Boeke 2005).  
 - 16 - 
 
Figure 1.6: Illustration of both chemical steps of splicing. Red arrow indicates the 
nucleophilic attack of the transesterification reactions. 
 
Over the past 20 years or so, many of the factors important for the two chemical 
steps of splicing have been identified and characterized to detail (Chen and Cheng 2012, 
Änkö 2014, Anczuków and Krainer 2016). Importantly, mutations in many of these 
factors have also been identified and well characterized and are known to cause 
perturbations in the splicing pathway (Vijayraghavan, Company, and Abelson 1989, 
Dreumont and Séraphin 2013). Particularly, these mutants can be taken advantage of to 
study the chemical steps of splicing in great detail. In this dissertation, mutants of two 
important such factors, Prp2 and Prp16, which function prior to the first and second 
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chemical steps of splicing, respectively (Figure 1.4, Will and Luhrmann 2011), have 
been leveraged to examine different aspects of the splicing pathway.  
Prp2 is an RNA-dependent DExD/H-box ATPase that is required for the 
activation of the spliceosome before the first transesterification step in RNA splicing 
(Kim and Lin 1996). Prp2 binds to a precatalytic spliceosome prior to the first step of 
splicing, and in concert with ATP hydrolysis causes a change in the overall spliceosome 
structure, “activating” the spliceosome for the first chemical step of splicing (Kim and 
Lin 1996, Liu and Cheng 2012). Prp2 is also important for destabilizing RNA elements 
that comprise the catalytic core of the spliceosome, both to proofread spliceosome 
activation and to promote reconfiguration of the spliceosome to a fully competent, 
catalytic fonrmation (Wlodaver and Staley 2014). Mutants that were identified in the 
Prp2 protein were found to accumulate unspliced RNAs from the vast majority of 
intron-containing genes (Gencheva et al. 2010). This is not surprising as one would 
imagine that blocking an important protein for the first chemical step of splicing would 
block the first step of splicing, and cause an accumulation of the reactants for that 
chemical reaction, the fully unspliced pre-mRNAs. In this dissertation, we make use of 
a prp2-1 temperature sensitive mutant in order to assess the effect of loss of Prp2 protein 
function on splicing (Kim et al. 1999). While strains harboring the prp2-1 mutation are 
able to grow with nearly wild type efficiency at 25°C, they are unable to support growth 
at 37°C (Kim et al. 1999). We have previously shown that genome-wide defects in pre-
mRNA splicing are apparent even after short times exposed to elevated temperature 
(Pleiss et al. 2007), making this mutant an excellent one to use to evaluate the 
consequences of blocking the first chemical step of splicing. 
Prp16, on the other hand, is a DEAH-box RNA helicase involved in the second 
catalytic step of splicing and in exon ligation (Umen and Guthrie 1995, Ohrt et al. 2013). 
The protein has been shown to also exhibit RNA-dependent ATPase activity which is 
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required for the second catalytic step of splicing (Schwer and Guthrie 1991). 
Furthermore, hPrp16 was shown via mass-spectroscopy to be highly associated with the 
activated spliceosomal C complex only, suggesting that it plays a role in the second step 
of splicing but is neither present nor necessary for the first (Schmidt et al., 2014). In 
vitro studies have shown Prp16 to promote ATP-dependent RNA unwinding activity, in 
a sequence-independent fashion, suggesting the mechanism of function of Prp16 lies in 
the disruption of a duplexed RNA structure in the spliceosome (Wang, Wagner, and 
Guthrie 1998). Mutants that were identified in the Prp16 protein were found to 
accumulate several lariat intermediates (Vijayraghavan, Company, and Abelson 1989). 
This is in line with the expectations that having a block in the second chemical step of 
splicing would cause an accumulation of a first step of splicing product accumulation. 
In this dissertation, we make use of a prp16-302 temperature sensitive mutant in order 
to assess the effect of loss of Prp16 protein function on splicing (Villa and Guthrie 
2005). Yeast strains carrying the cold-sensitive allele prp16-302 stall the release of the 
Prp16 protein at low temperatures and becomes unable to support growth at the non-
permissive temperature of 16°C. At the permissive temperature of 30°C, growth appears 
normal but it is unclear whether any silent molecular defects are present but hidden 
(unpublished data). At the non-permissive temperature, an increase in the lariat 
intermediates can be observed in conjunction with a decrease in the amount of mature 
mRNA (Villa and Guthrie 2005), further suggesting Prp16’s role in the second step of 
splicing, and making this mutant an excellent one to study effects from a defective 
second step of splicing.   
 
1.3: Structure of the spliceosome 
 As both the conformation and composition of the spliceosome are highly 
dynamic, understanding the 3-dimensional structure of the spliceosome at high 
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resolution has been a major challenge for the field (Will and Luhrmann 2011). Electron 
microscopy (Deckert et al. 2006, Fabrizio et al. 2009, Herold et al. 2009), NMR 
(Spadaccini et al. 2006) and x-ray crystallography (Oubridge et al. 1994, Price, Evans, 
and Nagai 1998, Vidovic et al. 2000, Kambach et al. 1999, Ritchie, Schellenberg, and 
MacMillan 2009) techniques have been employed to gain structural insights into many 
splicing factors either alone or coupled to their binding partners, but until recently, the 
structure of the whole and active spliceosome remain elusive. During 2015 - 2016, a 
series of papers came out that identified the structure of the whole spliceosome instead 
of single components.  
 One of the first spliceosomal subcomplexes for which a near atomic-level 
structure was solved was the U4/U6.U5 tri-snRNP of S. cerevisiae. At ~1.5 metadaltons, 
the tri-snRNP was structurally determined via single-particle cryo-electron microscopy 
(Cryo-EM) at an average resolution of 5.9 angstroms (Nguyen et al., 2015). Though 
incredibly insightful into the activation process and the active site of the spliceosome at 
the time, the resolution was not high enough to resolve many structural details. Shortly 
after, a high resolution structure was determined of an S. pombe spliceosome at an 
average resolution of 3.6 angstroms by Cryo-EM. This structure contained the U2 and 
U5 snRNPs, the Prp nineteen complex (NTC), the NTC-related (NTR) complex, U6 
snRNA and an RNA intron lariat. This structure had a combined molecular mass of ~1.3 
megadaltons, and represented a mixture of the previously described Bact, B*, and C 
complexes, as well as a post-catalytic (P) and intron lariat spliceosomal (ILS) complexes 
(Yan et al., 2015). This spliceosomal structure represented the first atomic resolution 
model of an intact, functional spliceosome and prompted a slew of other, more purified 
spliceosomal structures to be solved.  
One such spliceosome structure subsequently solved was the S. cerevisiae tri-
snRNP complex U4/U6.U5. By use of Cryo-EM, an overall resolution of 3.8 angstroms 
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was achieved (Figure 1.7, Wan et al. 2016). This massive, ~1 megadalton structure 
offered invaluable insights into the activation process of the spliceosomal ribozyme, 
confirming many known roles of splicing factors in addition to discovery of a few 
unknown factors. For example, the Dib1 protein in S. cerevisiae is postulated to play an 
important role in pre-mRNA splicing as suggested by both its central location in the tri-
snRNP and its association with U4 snRNA, the pre-mRNA, Prp31 and the central 
protein Prp8, even though its function remains to be determined.  
 
Figure 1.7: cryo-EM map for the yeast U4/U6.U5 tri-snRNP. Colors indicate 
resolution. Adapted from Wan et al. 2016.  
  
 Several months later, the atomic structure of the S. cerevisiae activated 
spliceosome obtained by Cryo-EM, also known as the Bact complex, had also been 
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reported, with an average resolution of 3.52 angstroms (Figure 1.8, Yan et al. 2016). 
The structure, including the 3 snRNAs and the pre-mRNA, has a combined molecular 
mass of ~1.6 megadaltons. The structural features identified from this structure 
confirmed the hypothesis in the field that the active site in the Bact complex has yet to 
be converted to a catalytically active site. There is a catalytic Mg2+ atom that is yet to 
be loaded into the active site location, which would require a minor conformation 
change in the U6 snRNA to happen. Importantly, the central component of the 
spliceosome, Prp8, which binds to all four RNA elements, displayed excellent 
resolution for the structure. This led to the discovery of a switch loop region (residues 
1402 to 1439) in the Prp8 protein which undergoes 180° flips between its 
conformation in the U4/U6.U5 tri-snRNP and that of the Bact conformation (Yan et al. 
2016). This rather important discovery led to the hypothesis that the switch loop plays 
an important function: that its close interaction with the splicing factor Cwc21 
preserves the connection between Cwc21 and the 5’ exonic sequences through both 
steps of splicing. This offered valuable insights into the way which spliceosomes are 
assembled and activated for catalysis. 
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Figure 1.8: cryo-EM map for the yeast Bact complex. Colors indicate resolution. 
Adapted from Yan et al. 2016. 
 
 At round the same time, the structure of the spliceosomal C complex was also 
solved via Cryo-EM at an average resolution of 3.4 angstroms (Figure 1.9, Wan et al. 
2016) and 3.8 angstroms by two different groups (Galej et al., 2016). This structure 
adds further support to the hypothesis that during this complex, the second step of 
splicing is poised to happen, but has not happened yet as the scissile phosphodiester 
bond has not been loaded onto the active site yet. What is worth noting, is that when 
comparing the C complex to the Bact, while most proteins conform to identical 
conformations, the ribonuclease H (RNaseH)-like domain of Prp8 exhibits a large 
positional shift of up to 99 angstroms (Wan et al. 2016). Despite being shifted between 
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structures, the RNaseH-like domains align to themselves with near perfect registry. 
Thus it is proposed that the domain itself is ridged, but serves as a highly mobile 
element in the various spliceosomal complexes.  
 The structural analysis of the different spliceosomal complexed tremendously 
aided our understanding of the mechanistic details of the steps of spliceosomal 
assembly and continued work in this area will contribute to helping the field answer 
questions such as how splicing fidelity and efficiency is achieved.   
 
Figure 1.9: Cryo-EM map for the yeast C complex. Adapted from Wan et al. 2016. 
   
 
1.4: Splicing is an important and essential process in biology 
Splicing is an important biological process and deeply involved in a wide area 
of topics ranging from gene expression regulation to protein diversity, to diseases. For 
example, the process of alternative splicing can generate additional protein variants 
from a single gene that contain many different introns. This phenomenon is especially 
telling when we compare humans, where there are about 20,000 genes present, to the 
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budding yeast S. cerevisiae, which has about 5000 genes. On the surface, it seems quite 
impossible that a 4-fold difference in gene numbers can generate the extreme 
complexities of humans compared to yeast. However, additional protein diversity is 
achievable via alternative splicing, generating many different mRNA isoforms from a 
single given gene (Nilsen and Graveley 2010). The alternative isoforms produced are 
also highly tissue dependent (Yeo et al. 2004), further increasing the diversity of 
proteins in humans. The increased protein diversity because of alternative splicing is 
essential in regulating tissue and organ development (Baralle and Giudice 2017). In 
addition to increasing protein diversity, splicing is also implicated in many diseases. For 
example, cystic fibrosis is a disease caused by the loss of function of the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene. Polymorphism in intron 8 of this 
gene affects exon 9 splicing which leads to a nonfunctional protein, directly contributing 
to the disease (Faustino and Cooper 2003). For researchers involved in monitoring these 
changes in gene expression, the substantial number of mRNA variants produced through 
alternative splicing increases the difficulty by which they can be monitored.  
 
1.5: Splicing is coupled to transcription 
Although it is possible to perform splicing in vitro using whole cell extract (Lin 
et al. 1985), suggesting that it is an independent process, we now know that splicing is 
connected to other cellular processes both temporally and spatially. Temporally, the 
process of splicing can happen as soon as the nascent RNA emerges from the 
polymerase, U1 and U2 deposition occur while transcription is still happening on the 
downstream portions of the RNA (Saldi et al. 2016). Spatially, the c-terminal domain 
(CTD) of RNA polymerase II is known to be associated with many splicing factors, 
such as the PRP19C complex (David et al. 2011). This coupling between splicing and 
other biological processes is difficult to model using in vitro studies, making them 
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somewhat less than ideal. To investigating splicing in its most native setting, in vivo 
studies are preferred, and a method that is able to accurately measure the splicing 
reaction in vivo is required.  
 
1.6: Yeast as a model organism for studying splicing 
The baker’s yeast S. cerevisiae is an excellent model organism used for studying 
splicing (Hossain and Johnson 2014). Being a highly tractable organism, genetic 
manipulation has been used with significant effect to study splicing in yeast. S. 
cerevisiae has a rather simple intronome, having lost most introns from its genome from 
its last eukaryotic common ancestor (Hooks, Delneri, and Griffiths-Jones 2014). Out of 
a total number of ~5000 genes, only about ~300 intron containing genes remain. 
Although baker’s yeast has a simple intronome, the core spliceosomal machinery is 
highly conserved, so findings derived from studies in baker’s yeast are often applicable 
to higher systems. Since many of the genes involved in gene expression regulation, 
including splicing, are essential, preventing studying by loss of function, the yeast 
model system provides an excellent alternative way of studying their mutants through 
temperature sensitive mutations. Finally, even though the number of intron containing 
genes are low in yeast and only make up ~5% of the genome, almost 40% of the 
transcriptome is made up of those intron containing genes (Ares, Grate, and Pauling 
1999). Their over representation signifies the key role they play for the transcriptome, 
which is an excellent system to have for understanding the splicing process.  
 
1.7: Historical methods used to monitor splicing 
Even though tremendous progress has been made in the field of splicing in the 
past decade, many important questions remain to be answered. For example, given the 
high degeneracy of splice sites, how does the spliceosome choose the “correct” site? 
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What are the cis and trans elements that affect splice site selection? What roles do cis 
and trans elements play in splice site fidelity? What roles do transiently associated 
factors to the spliceosome play in splice site selection and fidelity and what are the 
consequences of splicing mistakes? In order to probe these questions, we need a robust 
method to measure and quantify the changes in splicing caused by mutating these 
different factors. By studying mutants of these factors and observing the disruptions it 
causes in the splicing process, we can gain further understanding of the splicing process 
itself. 
When splicing was initially discovered, it was studied on a per transcript basis 
using in vitro tools (Berget, Moore, and Sharp 1977) where the different products of 
splicing, typically of different lengths, were resolved through gel electrophoresis. This 
method is excellent at qualitatively determining the presence or absence of the products 
of different steps of splicing, but not very quantitative in terms of determining the 
relative ratios of the different products. Furthermore, the throughput of this method is 
very low, and is not suitable for looking at large numbers of different splicing targets.  
Microarray hybridization techniques were then developed and provided a high-
throughput, global examination of splicing profiles where probes against many exon-
exon and intron-exon junctions are present on the array (Clark, Sugnet, and Ares 2002, 
Pleiss et al. 2007). Though relatively low cost for the amount of information gained per 
experiment, these microarray based approaches do suffer from several limitations. First 
of all, in order to construct the microarrays, prior knowledge of the sequences around 
the intron-exon and exon-exon boundaries must exist. This means the method isn’t 
suitable for detection of novel events, such as activation of cryptic splice sites. Secondly, 
high background noise levels are typical owing to partial hybridization of off-target 
transcripts (Okoniewski and Miller 2006), this makes quantitative assessment difficult, 
especially when comparing between samples. Finally, since hybridization techniques 
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usually rely on fluorescence labeled targets, dynamic range is poor as signal can often 
be saturated on the high end. This masks the observable range of splicing defect 
different mutants can have on the same transcript.  
 
1.8: Current methods used to monitor splicing 
With the rapid development of deep sequencing technology in the last decade or 
so, RNA-Seq had been quickly applied for use in field of splicing and has then become 
the standard used to monitor levels of splice isoforms. Because it does not rely on 
knowledge of existing genomic sequences, introns can be unambiguously annotated de 
novo at single nucleotide resolution from transcriptome data using computational 
techniques such as TopHat (Trapnell, Pachter, and Salzberg 2009). RNA-Seq also has 
no upper limit of detection, it is directly correlated to the number of reads obtained, and 
thus has an extremely high dynamic detection range.  
One example of RNA-Seq’s application in studying splicing is its use in the 
worm disease model of the retinitis pigmentosa (RP). RP is a group of genetically 
heterogeneous retinal diseases and a common cause of blindness. Surprisingly, 7 out of 
24 of the autosomal dominant RP genes identified encode ubiquitous proteins essential 
for splicing (Rossmiller, Mao, and Lewin 2012). Why specific mutations in these 
broadly expressed, conserved pre-mRNA processing factors, PRPF3, PRPF4, PRPF6, 
PRPF8, PRPF31, SNRNP200/BRR2, and RP9, seem to only affect the eye is poorly 
understood, and understanding the molecular mechanisms for how splicing is involved 
in RP pathogenesis will impact therapeutic approaches for RP (Mordes et al. 2009). 
Traditionally, most efforts in trying to understand RP have been focused on a small set 
of genes and proteins that are known to be relevant to the disease. With RNA-Seq, 
genome-wide profiling of gene expression changes in the background of RP becomes 
possible, and the genetically tractable C. elegans which expresses all the adRP genes 
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with the exception of RP9, is used as a shortcut to understand why a mild reduction in 
the activity of genes required in all cells is critical only for a specific tissue. With the 
aid of RNAi to partially knock down adRP genes, it is observed that in developing 
worms, RNAi treated samples show an intron retention phenotype compared to wildtype 
(Rubio-Peña et al. 2015). Though this is an important finding and provided the authors 
with the hypothesis that inefficient splicing in the retina, where cells present a high 
transcriptional activity, causes a reduction in the mRNA levels and subsequently a 
deficit in the amount of retinal proteins produced leading to retinal degeneration, it is 
nevertheless unsatisfying that no transcript specific conclusions are made. It is of no 
surprise that mutations in the splicing machinery designed to remove introns will cause 
increased intron retention. What would be instrumental in progression towards 
therapeutics development for RP is finding out specifically which transcript’s splice 
isoforms were altered to a detrimental degree, which this dataset was not able to find. 
For example, even at the depth of ~50 million reads per sample that the experiment was 
sequenced at, only 8 genes had enough depths to be quantitatively examined between 
the experiment and control samples and were found to not have changes in alternative 
splicing, despite ample RT-qPCR data suggesting PRPF8 depletion greatly alters 
alternative splicing (Tanackovic et al. 2011). This shows that despite RNA-Seq’s ability 
to accurately quantify gene expression across samples, it performs poorly when it comes 
to sampling and quantifying splice isoforms (Cloonan et al. 2008). 
The reason for RNA-Seq’s poor ability to quantify splice isoforms is simple: 
reads that are informative of splice isoforms are rare by nature. Only reads that cross 
junctions, either between intron and exon, or between exon and exon, are informative 
of a transcript’s splice isoform. This would mean that when using RNA-Seq to quantify 
transcript splice isoforms, only the small subset of junction spanning reads are useful, 
and all other reads are “wasted”. Since junctions make up only a tiny fraction of the pre-
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mRNA or mRNA, RNA-Seq reads that are splicing informative are rare, low count 
events (Figure 1.10). As an example, in S. cerevisiae, in a typical RNA-Seq experiment, 
only 0.3% of all reads map to splice informative junctions.  
 
Figure 1.10: Few reads from RNA-Seq are splice informative. Representation of splice 
informative reads in RNA-Seq for an example alternatively splice transcript is shown. 
Top panel represents canonically spliced product, bottom panel represents exon 
skipped product. Black lines represent mapped RNA-Seq reads that are not splice 
information, red lines represent reads that are splice informative. 
 
While a powerful technique for examining and comparing between high 
frequency events, what is less well understood is the challenges RNA-Seq face when 
quantifying low frequency events. RNA-Seq is inherently noisier when counts for an 
event are low due to the fact that read counts model after a negative binomial 
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distribution (Law et al. 2014), which means that as count frequency gets lower, the 
variance becomes higher (Love, Huber, and Anders 2014). This becomes a real problem 
when one is trying to quantify different low count species in a given state as well as how 
they change in an altered state. Many have thought about the problem and have come 
up with different ways to deal with it. Mathematical methods have emerged to increase 
the confidence of low read count events. One such example, the mixture of isoforms 
(MISO) model, uses additional information from lengths of library inserts in paired-end 
data, recasts the analysis of splice isoforms as a Bayesian inference problem in order to 
obtain a higher confidence interval for estimates of splice isoform abundance than RNA-
Seq without correction (Katz et al. 2010). However, even with proper mathematical 
corrections, RNA-Seq was still only able to accurately quantify splicing levels for ~55% 
introns in a ~140 million read mouse experiment (Herzel and Neugebauer 2015). This 
is particularly disappointing because ~140 million reads represent about half of the 
output of an Illumina NextSeq sequencing lane, and additional depth would mean that 
the experiment would quickly become cost prohibitive to perform, especially with the 
inclusion of multiple mutant conditions and replicates.  
One way of tackling the problem of lowly quantitated species is to specifically 
block their degradation, thus achieving passive enrichment. For example, when Dbr1, 
an enzyme crucial for the degradation of lariat intermediates, is knocked out in the 
fission yeast S. pombe, lariat intermediates accumulate and can be subsequently 
sequenced by RNA-Seq (Taggart et al. 2012, Awan, Manfredo, and Pleiss 2013, 
Stepankiw et al. 2015). However, even with this method, only a mere 0.25% of mapped 
reads come from lariat intermediates if they are not actively enriched first (Bitton et al. 
2014). Even though valuable information regarding 5’SS usage and branchpoint 
location is gained through the lariats identified, in general the per splice isoform counts 
are too low to be used in accurately quantitating splice isoform abundance vs. the 
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canonical isoform.  
To overcome RNA-Seq’s weakness with low frequency events, additional depth 
is the most crude and simple solution. However, even as the cost of RNA-Seq has come 
down dramatically over the last few years, increasing sequencing to the depth necessary 
to be able to precisely quantitate changes in splice isoforms is still cost prohibitive and 
folds higher than the depth that a typical experiment generates, especially when many 
mutants needs to be compared. Rather, a method that specifically enriches reads to 
targets of interest is required. 
 
1.9: Motivation for this dissertation 
In order to decipher the mechanistic details of the process of splicing, we are in 
need of a cost effective, accurate and precise method to globally monitor the products 
of both steps of splicing. Thus I have set out to develop one such method, Splice-Seq, 
which aims to utilize the depth gained through RNA-Sequencing and targeting that 
depth to specific regions of interest, namely the exon-exon and exon-intron junctions of 
intron containing transcripts. Splice-Seq can accurately quantify products of both 
chemical steps of splicing in a variety of conditions and mutant backgrounds at a low 
cost to the user. Though the technique is designed with the need of splicing in mind, it 
benefits from being easily modifiable into a wide variety of other targeted applications 
should it be desired. 
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Chapter 2: Splice-Seq as a novel targeted sequencing approach to study pre-
mRNA splicing 
2.1 Abstract: 
Most eukaryotic genes have their protein coding sequences interrupted by non-
coding introns, which must be removed from nascent pre-mRNAs by the spliceosome 
to generate a translatable mRNA. The past few decades have been marked by a 
significant increase in our appreciation for the central role that splicing plays in 
regulating eukaryotic gene expression. It is now clear that many organisms vastly 
expand their proteome by alternatively splicing pre-mRNAs to generate multiple protein 
isoforms from a single genetic locus, and that ever-increasing numbers of human 
diseases involve mis-regulation of this pathway. Nevertheless, the mechanisms by 
which this process is normally regulated, and can be mis-regulated with pathological 
consequences, remain poorly understood. 
Next-generation sequencing (NGS) technologies have had a profound effect on 
our understanding of pre-mRNA splicing. By identifying the small subset of reads that 
span exon-exon junctions, implementation of NGS via RNA sequencing (RNA-Seq) has 
enabled the unambiguous detection of vast numbers of novel splice isoforms generated 
within a cell. Yet in spite of the power presented by this approach, it is less widely 
appreciated that the depth of sequencing necessary to quantitatively detect many 
splicing isoforms is significantly higher than most RNA-Seq experiments generate. 
Indeed, because of the error associated with low count numbers, the paucity of splicing-
informative reads present in a standard RNA-Seq experiment significantly limits the 
ability to robustly assess quantitative changes in splicing patterns of specific transcripts 
in the background of different samples. As such, a deep understanding of the basic 
mechanisms by which splicing is regulated would benefit greatly from methods that 
enable higher resolution and precision detection of splicing states within cells. 
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Here I present the development and implementation of a novel sequencing 
method designed to harness the quantitative power of sequencing while focusing it on 
user-selected splice junctions of interest. This is accomplished through targeted reverse 
transcription where a pool of primers which anneal downstream of introns of interest 
are used instead of random priming. I demonstrate the ability of this approach to 
dramatically enrich the fraction of reads in a given sequencing experiment that are 
informative about splicing status, and in doing so enable a significant increase in the 
precision with which changes in splicing can be detected, all while decreasing 
experimental costs. Finally, I demonstrate the relative ease with which this approach 
can be adopted to diverse systems, facilitating a wide variety of experiments designed 
to understand the mechanistic underpinnings of splicing regulation. 
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2.2 Introduction: 
Most eukaryotic genes have their protein coding sequences interrupted by non-
coding introns. Intron removal is catalyzed by the spliceosome, a complex and dynamic 
macromolecule comprised of 5 small nuclear RNAs (snRNAs) and hundreds of 
proteins. Spliceosomes assemble anew on every splicing substrate, recognizing 
sequence motifs within and around the defined pre-mRNA boundaries, enabling intron 
removal via two sequential transesterification reactions (Will and Luhrmann 2011). The 
past few decades have been marked by a significant increase in our appreciation for the 
central role that splicing plays in regulating eukaryotic gene expression. For example, 
using both spatial and temporal regulation, it is now clear that many organisms vastly 
expand their proteome by alternatively splicing pre-mRNAs to generate multiple protein 
isoforms from a single genetic locus (Kelemen et al. 2013). Nevertheless, in spite of its 
central importance in the gene expression pathway, the mechanisms by which this 
process is regulated remain poorly understood.   
Over the past decade, next-generation sequencing (NGS) technologies have had 
a profound effect on nearly all facets of modern biology, including pre-mRNA splicing. 
NGS studies designed to understand the genetic underpinnings of various human 
diseases highlight the critical role of splicing in human biology: it is now estimated that 
as many as 50% of all genetically heritable human diseases impact the splicing pathway 
(Ward and Cooper 2010), either through mutations in the spliceosomal machinery itself, 
or through mutations within individual transcripts that alter their splicing. 
Simultaneously, implementation of NGS via RNA sequencing (RNA-Seq) has greatly 
expanded our understanding of the variety of spliced isoforms that can be generated 
within a cell. Identification of the small subset of reads that span exon-exon junctions 
within transcripts has enabled unambiguous detection of vast numbers of novel splice 
isoforms in scores of organisms (Trapnell, Pachter, and Salzberg 2009). Yet in spite of 
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the power presented by this approach, it is less widely appreciated that the depth of 
sequencing necessary to quantitatively detect many splicing isoforms is significantly 
higher than most experiments generate. Indeed, because of the error associated with low 
count numbers in RNA-Seq experiments (Katz et al. 2010), the paucity of splicing-
informative reads present in a standard RNA-Seq experiment not only limits the ability 
to detect minor splice isoforms within a given sample, but also the ability to robustly 
assess quantitative changes in splicing patterns of specific transcripts in the background 
of different samples. A deep understanding of the basic mechanisms by which splicing 
is regulated, and the pathological consequences of its mis-regulation, will benefit greatly 
from methods that enable higher resolution and precision detection of splicing states 
within cells. 
Here we present the development and implementation of a cost-effective, 
targeted sequencing approach that enables high precision detection of the genome-wide 
products of both chemical steps of pre-mRNA splicing. Though the technique is 
designed with the need of splicing in mind, it benefits from being easily modifiable into 
a wide variety of other targeted applications should it be desired. 
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2.3 Results: 
In order to better detect and understand genome-wide changes in pre-mRNA 
splicing, we designed and implemented a method, herein referred to as Splice-Seq, that 
enables targeted enrichment of sequencing reads at user-selected splice junctions. 
Building upon the historically validated use of primer extension as a tool for assessing 
splicing status, Splice-Seq was developed as a high-throughput variation of this 
approach coupled to sequencing as a tool for digital quantitation, a schematized 
depiction of which is presented in Figure 2.1A. As an initial test of this approach we 
designed an experiment to monitor pre-mRNA splicing in the budding yeast 
Saccharomyces cerevisiae, an organism for which the core spliceosomal machinery is 
highly conserved with multicellular organisms, yet which harbors a highly reduced set 
of introns within its genome, simplifying the process of genome-wide analyses. 
Primer Design: For each of the 309 annotated introns within the budding yeast 
genome, a reverse transcription primer was designed within the first 50 nucleotides 
downstream of the intron. Targeting to this region ensured that short-read sequencing 
of the products generated from reverse transcription with these primers would cross the 
upstream exon-exon or exon-intron boundaries, enabling determination of the splice 
isoform. Primers were designed using OligoWiz, a program initially developed for 
microarray probe design, but which enables the selection of primer sequences optimized 
for target specificity relative to a designated genomic background (Wernersson, 
Juncker, and Nielsen 2007). To the 5’ end of each of these primers was appended two 
additional sequence elements: an 8 nucleotide random region which allows for the 
detection and removal of amplification artifacts arising from library preparation 
(Shiroguchi et al. 2012); and the P500 region of the Illumina sequencing primer to 
enable the sequencing of the reverse transcription products. Each of these primers was 
individually synthesized, the full sequences of which are provided in the supplemental 
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materials for Xu et al. 2018, in preparation. 
 
Figure 2.1:Splice-Seq can quantitatively monitor splice isoforms. (A) Schematic 
showing the workflow of Splice-Seq. (B) Splice-Seq mapping percentages for S. 
cerevisiae. (C) Coverage visualization for Splice-Seq mapping to example genes Tef5 
and Yra1. (D) Five example genes and their isoform numerical data from Splice-Seq 
are shown. 
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Targeted cDNA synthesis: Beginning with total cellular RNA, cDNA was 
synthesized in a reaction containing a total of 1µg of primer, consisting of equimolar 
amounts of each of the 309 individual primers. Reactions were performed under 
generally standard conditions (see Methods for additional details) but in the presence of 
the nucleotide analog aminoallyl-dUTP (aa-dUTP) in order to facilitate recovery of 
cDNA products. In order to increase primer specificity and decrease off-target 
annealing, reactions were incubated at 47°C. After removal of the RNA and 
unincorporated aa-dUTPs, the extended cDNA molecules were biotinylated through the 
incorporated aminoallyl-dU residues by reaction with NHS-biotin. The biotinylated 
cDNA was then purified using streptavidin beads, enabling removal of the excess of 
unextended primers. 
First strand extension: Conversion of the products of these reverse transcription 
reactions into sequence-able material was accomplished using a modified version of 
second strand synthesis that enabled preservation of the 3’ end of the cDNA products. 
We employed a strand extension technique that included as a ‘second strand primer’ a 
dN9 template oligo with a blocked 3’ end that was incapable of being extended by 
Klenow (Hexanediol Spacer from Integrated DNA Technologies), and to which the 
Illumina P700 sequence was appended on its 5’ end. Whereas these molecules can 
anneal via the random region to virtually any portion of the generated cDNA products, 
they cannot be extended by Klenow by virtue of their blocked 3’ ends. By contrast, 
when these primers anneal to the 3’ terminus of the cDNA product, Klenow can extend 
the first strand products by appending the Illumina P700 sequence. After re-purification 
of the extended first strand products and removal of the ‘second strand primers’ by 
streptavidin purification, the products of these first strand extension reactions were 
amplified using primers containing Illumina sequences that enabled bar-coded library 
preparation.  
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Splice-Seq determines the splicing status of intron containing transcripts with high 
precision: 
As an initial implementation of Splice-Seq, we designed a sequencing 
experiment with a targeted depth of approximately 5 million reads. While this level of 
sequencing corresponds to just a small fraction (1-2%) of the capacity of a single run 
on an Illumina NextSeq, on the basis of total expression levels derived from published 
RNA-Seq datasets we estimated that this would provide sufficient depth to sample the 
majority of splice junctions (Nowrousian 2013). Libraries were generated according to 
the protocol described in Figure 1A (see also Methods for details), and subsequently 
sequenced on an Illumina NextSeq. For reasons that will be described more completely 
later, the sequencing was performed such that 60 nucleotides were sequenced from the 
forward end of our library (corresponding to the splice junction region) and 15 
nucleotides were sequenced from the reverse end (corresponding to the terminus of the 
cDNA). Paired-end reads were aligned using the Star Aligner with typical settings (see 
Methods).  
To assess the effectiveness of Splice-Seq for enriching splicing-informative 
reads, we first asked about the overall alignments generated by this experiment. As seen 
in Figure 1B, over 75% of the reads were splicing informative, meaning that they were 
derived from one of the 309 designed primers, and reflected extension of a cDNA 
product across the upstream splice junction. By contrast, only a small fraction (~1%) of 
the reads aligned to regions not targeted by one of the designed primers, in most cases 
reflecting cross-hybridization with a poorly matched region within a highly expressed 
RNA (Figure 2.2). Similarly, a small fraction (~2%) of the reads reflected unextended 
primers, wherein the synthesized primer sequences appeared directly appended to the 
reverse Illumina primer. The remaining ~20% of the reads reflected a combination of: 
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on-target, splicing informative reads that nevertheless contained too many mismatches 
to allow for proper alignment; and low information sequences that were likely 
amplification or sequencing artifacts. Taken together these data confirmed the ability of 
this approach to efficiently target sequencing reads to regions of interest.  
 
Figure 2.2: A small percentage of reads are mapped to off target transcripts due to 
partial matches in the primer sequence. The primer (blue) has partial mismatches to 
the off target transcript PDC1 (orange) and resulted in ~500 reads of the off target 
cDNA synthesized. The on target transcript RPL14B (green) has ~6000 reads. 
 
In order to assess the ability of this approach to quantify splicing status, we 
examined the reads that were aligned to individual intron-containing genes. For the vast 
majority of genes, the data were consistent with the idea that levels of spliced mRNA 
are higher than unspliced mRNA in the steady state pool, in that most reads span the 
exon-exon boundary rather than reading from the downstream exon into the intron. 
Figure 1C shows examples of the read coverages associated with two genes, Tef5 and 
Yra1, and Figure 1D shows the quantitation for several additional genes (the full data 
are available in the supplemental materials of Xu et al. 2018 once published). 
Importantly, whereas the Tef5 transcript showed a high partitioning towards spliced 
mRNA, where tens of thousands of reads corresponded to the mature isoform but just 
under 100 reflected the presence of pre-mRNA, a much higher fraction of unspliced 
mRNA was detected for Yra1 (see lower inset of Figure 1C), a transcript that has 
previously been shown to be auto-regulated through its slow rate of pre-mRNA splicing. 
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Indeed, the steady-state splicing efficiencies determined from these data were largely 
consistent with previously reported values (Pleiss et al. 2007). 
 
Figure 2.3: Read count distributions for both premature mRNA and mature mRNA are 
high in a 5 million read Splice-Seq experiment. Count distributions for both species 
are shown. Box covers 25th – 75th percentiles. Line inside box represents the mean. 
 
Given the strong enrichment of reads targeted to the splice junctions in this 
initial experiment, we sought to examine the precision with which Splice-Seq measured 
splicing efficiency, particularly in comparison with RNA-Seq. Because robust numbers 
of reads were generated for both the spliced and unspliced isoforms of nearly every 
intron-containing gene (Figure 2.3), we expected that Splice-Seq would not be subject 
to the same level of sampling-related noise apparent in most RNA-Seq datasets, and 
would therefore yield more precise measurements of splicing efficiency. To test this, 
replicate Splice-Seq libraries were generated from a wild type sample of RNA using the 
previously described protocol, while additional replicate RNA-Seq libraries were 
generated using NEB’s RNA sequencing kit (following manufacturer’s protocol). 
Whereas the Splice-Seq libraries were again targeted for ~5M reads of sequencing each, 
the RNA-Seq libraries were targeted for ~30M reads each, a level more commonly used 
in RNA-Seq experiments (Sims et al. 2014, Conesa et al. 2016). For each intron-
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containing gene we then calculated the percentage of total reads mapping to the intron 
that reflected unspliced mRNA. As seen in Figure 2.4A, Splice-Seq generated highly 
reproducible values for transcripts across a wide spectrum of relative splicing 
efficiencies (R2=0.96), consistent with the robust count numbers generated even for 
lowly expressed transcripts within this small dataset. Importantly, while we did not filter 
these data for a minimum read number, splicing efficiencies could be calculated in both 
replicate libraries for over 90% of the intron-containing genes, meaning that at least one 
read was detected for both splicing isoforms within both libraries. As an initial, direct 
comparison, the RNA-Seq libraries were downsampled to 5M reads apiece (the same 
size as the Splice-Seq libraries) with the percent unspliced again calculated for every 
intron-containing gene. Two important conclusions are apparent from these data, as 
shown in Figure 2.4B. First, splicing efficiencies could not be calculated for nearly 20% 
of the intron-containing genes because at least one isoform failed to be detected in at 
least one of the samples, reflecting the relatively low frequency at which short-read 
sequences traverse splice junctions in a traditional RNA-Seq experiment. Second, for 
the subset of intron-containing genes for which splicing efficiencies could be 
determined, the reproducibility was significantly worse than Splice-Seq (R2=0.59). 
When considering the full, 30M read RNA-Seq datasets, as seen in Figure 2.4C, the 
number of intron-containing genes for which splicing efficiency could be calculated 
returned to a level equivalent to Splice-Seq, yet the reproducibility continued to lag 
behind (R2=0.86) even with the significant increase in sequencing depth (and associated 
cost). To better understand the level of enrichment that Splice-Seq provided over RNA-
Seq in these experiments, the number of exon-exon reads generated for each intron-
containing gene was determined for each method, normalized to the total number of 
reads generated. As seen in Figure 2.4D, these data suggest a median enrichment of over 
200-fold. 
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Figure 2.4: Splice-Seq can more precisely quantify splicing efficiencies than RNA-
Seq using less depth. Fraction unspliced (premature counts/(premature counts + 
mature counts)) is calculated for wildtype biological replicates of BY4741 strain. 
Biological replicates are plotted on log log correlation plots shown for a 5M read 
Splice-Seq experiment (A), 5M read RNA-Seq experiment (B), and 30M read RNA-
Seq experiment (C). Exon-exon count enrichment on a per transcript basis is plotted as 
a scatter plot in (D). 
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Splice-Seq robustly quantifies changes in splicing efficiency. 
While understanding the splicing efficiency of transcripts in a particular state is 
important, for many researchers the critical metric to understand is how splicing 
efficiency is altered with changes in developmental or genetic condition. To confirm 
that Splice-Seq could robustly quantify changes in splicing efficiency between two 
different samples, we took advantage of a budding yeast strain containing a mutation in 
the well characterized spliceosomal factor Prp2 (Kim and Lin 1996). Prp2 is a helicase 
necessary for catalyzing a structural rearrangement in the spliceosome required for the 
first chemical step, and while strains harboring the prp2-1 mutation are able to grow 
with nearly wild type efficiency at 25°C, they are unable to support growth at 37°C 
(Kim et al. 1999). We have previously shown that genome-wide defects in pre-mRNA 
splicing are apparent even after short times exposed to elevated temperature (Pleiss et 
al. 2007). To determine the capacity of Splice-Seq to detect changes in splicing 
efficiency associated with this mutant, we harvested RNA from matched wild type and 
prp2-1 mutant strains, each of which had been shifted to the non-permissive temperature 
for 15 minutes. Figure 2.5A shows how splice efficiencies for a few example genes 
change in prp2-1 with respect to wildtype under non-permissive temperatures. As 
before, we generated replicate Splice-Seq libraries from each of these strains as well as 
replicate RNA-Seq libraries, then sequenced each of them to generate ~5M and ~30M 
read datasets, respectively. As expected, Splice-Seq robustly and reproducibly 
(R2=0.92) measured the changes in splicing efficiency across a wide dynamic range, as 
seen in Figure 2.5B. Similarly, as previously demonstrated RNA-Seq showed far lower 
reproducibility at equal (5M) read depths (R2=0.67, Figure 2.5C) and even at 
significantly elevated read depths (R2=0.82, Figure 2.5D). 
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Figure 2.5: At the non-permissive temperature, prp2-1’s splicing defect can be 
precisely captured by Splice-Seq. (A) Change in fraction unspliced when shifted to the 
non-permissive temperature is shown for 6 example transcripts. Change in fraction 
unspliced for biological replicates are plotted against each other in panels (B), (C) and 
(D) for Splice-Seq at 5M reads, RNA-Seq at 5M reads and RNA-Seq at 30M reads 
respectively. 
 
Splice-Seq can identify and differentiate between splicing intermediates 
Our initial experimental design for second strand synthesis anticipated the 
possibility that this approach might enable detection of the locations of reverse 
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transcription stops. In its early use for studying pre-mRNA splicing, primer extension 
assays were often used to identify the lariat intermediate species that are generated after 
the first but prior to the second chemical steps of splicing (see Figure 2.7A) on the basis 
of a strong reverse transcription stop at the branched adenosine in the lariat intermediate 
(Coombes and Boeke 2005). Because the locations of introns within budding yeast 
genes show a strong positional bias towards the extreme 5’ end, we imagined that most 
reverse transcription products generated in these experiments would extend to the 
natural 5’ end of the mRNAs. In fact, as seen in the coverage map of the Tef5 transcript 
in Figure 1C, a large number of reverse reads (those derived from the 3’ end of the 
cDNA products) mapped to a region near the expected transcription start site (TSS) for 
this gene. While a range of similar but distinct global TSSs have been described in 
budding yeast using a variety of techniques (Pelechano et al. 2014, Booth et al. 2016, 
Zhang and Dietrich 2005), a comparison of the reverse transcription stops generated in 
our experiment with the predicted TSSs from these different studies all showed strong 
correlations (see Figure 2.6), consistent with the capacity of Splice-Seq to reveal the 
locations of reverse transcription termination. 
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Figure 2.6: TSS mapped by Splice-Seq correlates well with existing datasets. TSS 
from Splice-Seq is mapped against TIF-Seq, Pro-Cap and 5’ SAGE in panels (A), (B) 
and (C) respectively. Top panels show average cDNA end position centered around 
the annotated TSS from the indicated mapping methods. Bottom panels visualizes read 
count density normalized to 100 for all transcripts containing data on cDNA end 
positions centered at the annotated TSS from the indicated mapping methods. 
 
Having demonstrated the capacity to map reverse transcription stop sites, we 
asked whether data from Splice-Seq could be used to differentiate between unspliced 
reads where reverse transcription proceeded beyond the branchpoint adenosine 
(presumably reflecting unspliced pre-mRNA which had not yet undergone the first 
chemical step of splicing) and those where reverse transcription stopped at the 
branchpoint adenosine (presumably reflecting the lariat intermediate product of the first 
chemical step). For each nucleotide within each intron-containing gene, we determined 
the fraction of cDNA molecules that included that position, the results of which are 
shown in Figure 2.7B. The upper portion of this figure shows the composite behavior 
as seen across all 254 transcripts detected in this experiment, whereas the lower portion 
shows a false-colored representation of each of the individual transcripts. When the data 
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were considered from right to left (that is, as the reverse transcription event moved from 
the 3’ splice site towards the 5’ splice site), a gradual decrease in read density was 
apparent, presumably reflecting the background rate of reverse transcription 
termination, mostly likely owing to poor processivity of the enzyme or random cleavage 
events in the underlying RNA. By contrast, a sharp decrease in read density was 
apparent precisely at the location of the annotated branchpoint, consistent with a strong 
stop in reverse transcription at this location. Interestingly, comparison of the profiles for 
individual transcripts revealed a wide variety of phenotypes: some transcripts showed 
relatively low fractions terminating at the branchpoint, consistent with a large 
population of unspliced mRNAs prior to the first chemical step, while others showed 
high fractions of lariat intermediate.  
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Figure 2.7: Splice-Seq is able to detect branchpoint accumulation in different splicing 
mutants. (A) Visualization of different end positions for termination of reverse 
transcriptase. (B) through (F) (B: wildtype under normal growth condition, C and D: 
wildtype and prp2-1, E and F: wildtype and prp16-302) Top panels: percentage of 
intronic cDNA reads terminating at each location centering at -10 to +10 bp of the 
annotated branchpoint A through the 3’ splice site for each transcript. Normalized to 
100% at the 3’ splice site. Bottom panels: graphical representation of the intronic 
percentage of cDNA reads terminating at the same locations. Note: the apparent minor 
but sharp decrease located ~3 bp downstream of the annotated branchpoint A comes 
from a data processing artefact related to first strand extension primer having sequence 
overlap with the reverse Illumina sequence and is not biologically relevant. 
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To confirm that the reverse transcription stops we detected were indeed a result 
of the branched lariat structures, we returned to our mutant alleles. Using in vitro 
splicing systems, others have previously demonstrated that extracts from prp2-1 strains 
are unable to catalyze the first chemical step of splicing: formation of the lariat 
intermediate (Silverman et al. 2004). As such, we performed a similar analysis on the 
libraries derived from our strain harboring the prp2-1 mutation and its matched wild 
type. As seen in Figure 2.7C and D, whereas the strong reverse transcription stop 
remained apparent in the wild type sample, in the prp2-1 sample there was little if any 
detectable lariat intermediate on either a global or transcript-level basis, consistent with 
the absence of lariat intermediate products in this sample. To augment this result, we 
designed a complementary experiment: whereas Prp2 is a helicase that functions 
immediately prior to the first chemical step, Prp16 is a helicase that functions after the 
first chemical step but prior to the second, as such we expected that mutations impairing 
Prp16 function would lead to an accumulation of lariat intermediates genome-wide with 
a concomitant decrease in the amount of fully unspliced pre-mRNA (Hogg et al. 2014). 
Splice-Seq libraries were generated from RNA from a strain harboring a prp16-302 
mutation along with a matched wild type strain after both had been shifted to the non-
permissive temperature. Surprisingly, while accumulation of pre-mRNA was detected 
genome-wide in the prp16-302 sample (see Figure 2.8A C and D), as seen in Figure 
2.7F, the relative proportion of lariat intermediate present was largely unchanged, 
consistent with the idea that both the first and second chemical steps were defective. 
Although the time spent at the non-permissive temperature was relatively short for these 
samples, we imagined that inactivation of Prp16 could ultimately lead to a general defect 
in splicing if sub-stoichiometric components of the spliceosome became sequestered 
with stalled prp16-302-associated spliceosomes. We therefore generated additional 
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Splice-Seq libraries from the prp16-302 strain shifted to the non-permissive temperature 
for a variety of very short times. Remarkably, while these samples clearly revealed time-
dependent increases in global pre-mRNA levels (Figure 2.8C) and global lariat 
intermediate levels (Figure 2.8D), the relative amount of fully unspliced pre-mRNA 
versus lariat intermediate was nearly identical at all times, as shown in Figure 2.8B. 
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Figure 2.8: Continued on next page. 
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Figure 2.8: Continued from previous page. Time dependent lariat intermediate and 
pre-mRNA accumulation is observed for prp16-302 but relative levels stay constant. 
(A) Top panels: Average counts for cDNAs terminating at positions centered at -10 to 
+10 bp of the annotated branchpoint A through the 3’ splice site for each transcript. 
Bottom panels: Graphical representation for counts at each basepair location centering 
at -10 to +10 bp of the annotated branchpoint A through the 3’ splice site for each 
transcript. (B) Top panels: percentage of intronic cDNA reads terminating at each 
location centering at -10 to +10 bp of the annotated branchpoint A through the 3’ 
splice site for each transcript. Normalized to 100% at the 3’ splice site. Bottom panels: 
graphical representation of the intronic percentage of cDNA reads terminating at each 
location centering at -10 to +10 bp of the annotated branchpoint A through the 3’ 
splice site for each transcript. Normalized to 100% at the 3’ splice site. (C) and (D) 
Counts of cDNAs terminating around the branchpoint A (+/- 4bp), or anywhere within 
the intron, respectively, is plotted over the time course. Normalized to sample read 
depth. 
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An efficient method for generating complex pools of Splice-Seq primers. 
Although the above work demonstrated the capacity of Splice-Seq to robustly 
monitor global splicing status, the utility of the approach as described would be limited 
to those organisms for which it was economically feasible to synthesize the full 
complement of needed primers. While it would quickly become cost prohibitive to 
individually synthesize the thousands of discrete oligonucleotides necessary undertake 
experiments in an organism with complex splicing, many commercial sources exist 
today wherein tens or even hundreds of thousands of oligonucleotide sequences can be 
generated in a complex mixture, often utilizing microarray synthesis technologies. 
Although the quantity of any given oligonucleotide generated by these methods is 
vanishingly small, we designed a protocol by which these could be used as a template 
to generate microgram quantities of single-stranded primers, a schematic of which is 
shown in Figure 2.9A (see also Methods for details). Briefly, to the 3’ end of each of 
the primer sequences presented in the supplemental table (available online once this 
work is published at Xu et al. 2018), we appended two additional motifs. First was a 
SapI restriction site, designed such that cleavage with SapI would generate the precise 
3’ end of the primers shown in the mentioned supplemental table. Second was a constant 
sequence: PCR reactions were then performed using a reverse amplification primer 
complementary to this constant sequence along with an Illumina forward primer 
(present on the 5’ end of each of the designed oligos in the supplemental table). For 
reasons described below, the forward Illumina primer in these reactions was synthesized 
with a three carbon block on its 5’ end, while the reverse amplification primer was 
synthesized with a biotin on its 5’ terminus. After amplification with these primers and 
digestion with SapI, treatment with Lambda Exonuclease preferentially degraded those 
strands with a 5’ phosphate generated by SapI digestion. The desired single stranded 
oligonucleotides were then purified by depleting all biotin-containing species, affecting 
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removal of both the single stranded reverse primer regions as well as any double 
stranded molecules that failed to undergo SapI digestion. As seen in Figure 2.9B, this 
approach allowed for robust generation of single stranded, pooled primers. To 
demonstrate the activity of these primers, they were used to generate replicate Splice-
Seq libraries from the same wild type RNA we previously used. As before, the global 
splicing efficiencies determined from these replicate experiments were very well 
correlated with one another and importantly, a comparison of data generated with the 
different sources of primers also show a very high correlation (R2=0.91, Figure 2.9C). 
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Figure 2.9: Complex pools of oligo mixtures can be generated to be used for priming 
in Splice-Seq. (A) Schematic showing the complex pool generation process. (B) 6% 
acrylamide gel showing the products of each purification step. 100 bp ladder used in 
for sizing. The PCR product is shown in 1. Column purified PCR products to its right. 
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SapI cleaved product shown in 2. Lambda exonuclease digested, single stranded 
products shown in 3. Streptavidin purified product shown in 4. Control lane shows 
pure mixture of oligo primers ordered individually. (C) Correlation between fraction 
unspliced generated from Splice-Seq libraries primed with either complex oligo 
mixture or individually synthesized and pooled mixture. 
 
Splice-Seq can be scaled to query thousands of target locations 
Having demonstrated that pooled oligonucleotide synthesis was a viable 
approach for generating Splice-Seq primers, we sought to determine whether this 
approach would be similarly robust in systems with far greater splicing complexity. To 
assess this, we turned to the fission yeast, Schizosaccharomyces pombe, an organism 
that shares many genetic properties with its distantly related cousin S. cerevisiae, but in 
many ways more closely resembles mammalian splicing. The S. pombe genome encodes 
thousands of introns, including thousands of genes with multiple introns, and 
widespread examples of alternative and aberrant splicing have been demonstrated 
(Awan, Manfredo, and Pleiss 2013). Using the lessons we learned in budding yeast, we 
designed a pool of ~4000 oligonucleotides, each targeting an individual intron within 
the S. pombe genome. Following the procedure outlined in Figure 2.9A, we amplified 
the S. pombe-specific primers, and then used them to generate replicate Splice-Seq 
libraries from RNA derived from a wild type strain of S. pombe. The results of these 
experiments were in line with the previously described experiments, with some 
important differences. As seen in Figure 2.10A, while a smaller fraction of the reads 
reflected splicing informative primer extension reactions, that subset of reads 
nevertheless provided similar information about splicing status across thousands of 
splicing events in S. pombe (Figure 2.10B). By contrast, for reasons that are yet unclear 
but remain under investigation, a much higher percentage of the reads generated in this 
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experiment were either unmappable or reflected the cloning of unextended primers. 
Similar artifacts plagued early attempts at Splice-Seq in S. cerevisiae but were rectified 
with changes to library purification steps; we expect similar iterations to yield increased 
purity for these S. pombe libraries as well. 
 
 
Figure 2.10: Splice-Seq can be upscale to query thousands of target locations. (A) 
mapping distributions for Splice-Seq in S. Pombe. (B) Example multi-intron gene 
coverage for rpl22. 
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2.4 Discussion: 
Here we have described the development and implementation of a targeted 
sequencing method, which we call Splice-Seq, that was designed to measure changes in 
pre-mRNA splicing state with increased precision but decreased cost relative to 
traditional RNA-Seq. Whereas the majority of reads derived from most RNA-Seq 
experiments map directly to exonic regions and therefore lack direct information about 
splicing state, Splice-Seq targets these reads to splicing junctions through the use of 
user-selected primers during reverse transcription. Our initial experiments in the 
budding yeast S. cerevisiae demonstrated an increase in sensitivity of over two orders 
of magnitude as compared with RNA-seq (Figure 2.4D). We simultaneously described 
a method that allows for robust generation of pools of single stranded primers of user-
selected identity that readily enable the application of Splice-Seq to any set of splicing 
events within any organism (Figure 2.9). Together, these tools should enhance the 
ability of researchers to interrogate a variety of aspects of pre-mRNA splicing. 
An important example of the novel type of information that can be derived from 
the increased resolution provided by Splice-Seq is our demonstration of the ability to 
distinguish between fully unspliced and lariat intermediate versions of pre-mRNA. To 
our knowledge, no previous method has allowed for the in vivo differentiation of these 
species on a global scale. The ability to distinguish between these products in vivo, 
particularly when coupled to methods for rapid metabolic labeling of nascent RNAs 
(Rädle et al. 2013, Schwarzl et al. 2015, Oesterreich et al. 2016), provides a profound 
opportunity to kinetic behavior of the global complement of splicing substrates not only 
under standard conditions but also in the context of changes environmental or genetic 
conditions. Indeed, whereas the spliceosomal helicase Prp16 has long been associated 
with a structural rearrangement of the spliceosome necessary for the second chemical 
step, and while proteomic studies have only detected its stable presence in complexes 
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with the spliceosome after completion of the first chemical step, our demonstration here 
that strains harboring the prp16-302 allele accumulate products consistent with both a 
first and second step defect suggest that the role of this factor may be more expansive 
than originally thought (Figure 2.7). Additional experiments will be necessary to 
determine whether the results presented here reflect a primary role for Prp16 during the 
first chemical step of splicing, or whether they reflect downstream consequences of this 
mutation. We expect the tools presented here will provide the opportunity to address 
both this question and others like it. 
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2.5 Materials and methods: 
Strains and cell growth:  
The wildtype strain used in the experiments presented here was BY4741. The 
mutant prp2-1 and prp16-302 strains were both obtained from the Guthrie lab. BY4741 
was paired with both prp2-1-ts and prp16-302-ts and underwent either heat or cold shift 
respectively before collection. Heat shifted strains were grown in YPD at 25°C until 
saturation, then back diluted to OD 0.05 and grown until ~OD 0.7 at which point the 
temperature of the growth medium was raised to 37°C by addition of an equal volume 
of fresh 50°C YPD for 15 minutes before cells were collected by filtration. Similarly, 
cold shifted strains were grown in YPD at 30°C until saturation, then back diluted to 
OD 0.05 and grown until ~OD 0.7 at which point the temperature of the growth medium 
was reduced to 16°C by addition of an equal volume of fresh 0°C YPD for 15 minutes 
before cells were collected by filtration. Cell pellets were frozen in liquid nitrogen and 
stored at -80°C until RNA extraction.  
 
Splice-Seq library preparation:  
RNA extraction: RNA was isolated and then DNase treated using standard 
methods according to Inada and Pleiss 2010.  
cDNA synthesis and cleanup: 10 µg of DNase treated total RNA was used as 
input per library where 1 µg of gene specific primer pool (each gene specific primer at 
equimolar ratio) was added and annealed by heating at 70°C for 1 minute, 65°C for 5 
minutes, then cooled down and held at 47°C. An equivalent volume of MMLV reverse 
transcriptase enzyme mix containing 1 mM dATP, 1 mM dGTP, 1 mM dCTP, 0.4 mM 
aminoallyl-dUTP and 0.6 mM dTTP and appropriate buffers and salts was pre-heated 
to 47°C and added to the primer-annealed RNA mix. Reactions were incubated at 47°C 
for 3 hours, followed by heat inactivation at 85°C for 5 minutes. Remaining RNA was 
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hydrolyzed by addition of ½ volume of 0.3M NaOH with 0.03M EDTA and incubated 
at 65°C for 15 minutes. After neutralization with ½ (original) volume of 0.3M HCl, the 
cDNA was purified with a Zymo 5 column using 7X volume binding buffer (2M 
guanidinium-HCl, 75% isopropanol, Zymo Research C1003-50) following 
manufacturer’s protocol. Purified cDNA samples were dried in a SpeedVac for further 
processing.  
NHS ester biotin coupling: Purified cDNA pellets were resuspended in 18 µL of 
fresh 0.1M Sodium Bicarbonate pH 9, to which was added 2 µL of 0.1 mg/µL NHS-
biotin (ThermoFisher 20217, dissolved in DMSO); reactions were incubated at 65°C for 
1 hour. cDNA was purified from unreacted NHS-biotin using Zymo columns, again 
using 7X volume binding buffer and following the manufacturer’s protocol. 
Streptavidin-biotin purification: Biotin-labeled cDNAs were purified in a 
reaction containing 20 µL of Dynabeads MyOne Streptavidin C1 (ThermoFisher 
65601). Dynabeads were pre-washed twice in 500 uL of 1X binding and washing buffer 
(5 mM TrisHCl pH 7.5, 0.5 mM EDTA and 1M NaCl, as per manufacture’s protocol) 
prior to use. Washed beads were resuspended in 2X binding and washing buffer and 
were combined with the purified cDNAs in a total of 100µL and allowed to rotate for 
30 minutes at room temperature. Bound material was washed twice with 500 µL of 1X 
binding and washing buffer, then two more times with 100 µL of 1X SSC. To ensure 
purification of only single-stranded cDNAs, pellets were then incubated with 0.1M 
NaOH for two consecutive 10 minute washes. Finally, the bound material was washed 
3 times with 1X TE before the purified cDNA was eluted by heating the sample to 90°C 
for 2 minutes in the presence of 85 µL of 95% formamide, 10 mM EDTA. The eluate 
from this step was then purified again using a Zymo column using 7X volume binding 
buffer following the manufacturer’s protocol.  
First strand extension: The dN9-anchored Illumina reverse Nextera primers were 
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annealed to the first strand by heating the purified cDNA in the presence of 2 µM 
primers to 65°C for 5 minutes, then cooling down to room temperature. Klenow exo- 
fragment (NEB M0212S) was added and the reactions incubated for 5 minutes at room 
temperature, after which they were moved to 37°C for 1 hour. Purification of the 
products of this reaction by streptavidin was accomplished according to the same 
procedure described above.  
PCR amplification: Amplification of the reaction products was accomplished by 
using ¼ of the material generated as a template in a PCR reaction. Illumina Nextera (i5) 
and (i7) adapters were used in a standard 50 µL PCR reaction with Phusion polymerase 
(ThermoFisher F530S). Cycling conditions were as follows: denaturation at 95°C for 
10 sec; annealing at 62°C for 20 sec; and extension at 72°C for 30 sec. Libraries 
typically required between 14 and 20 cycles of amplification, depending upon the 
amount of starting material. Amplified material was purified using 6% native PAGE 
stained with SyBr gold (ThermoFisher S11494), where material in the range from 200bp 
to 800bp was extracted.  
 
Complex oligo mix amplification method:  
PCR amplification: Using Phusion polymerase under standard PCR conditions, 
double-stranded amplicons were generated from the single-stranded oligos obtained 
from LCSciences using 14 rounds of PCR in a 400µL reaction containing: 1% of the 
pooled oligonucleotides from LCSciences as a template, an Illumina forward primer 
containing a C3 spacer (Integrated DNA Technologies) at its 5’ end, and a reverse 
amplification primer containing a biotin-label at its 5’ end. Cycling conditions were as 
follows: denaturation at 95°C for 10 sec; annealing at 60°C for 20 sec; and extension at 
72°C for 30 sec. Upon completion of this initial reaction, the entire reaction was used 
as a template to seed a larger (4mL) PCR reaction. For efficient amplification, this large 
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reaction was performed in two 96-well plates with 50µL in each well. Reaction 
conditions were identical to those described for the first reaction, and a total of 14 cycles 
were performed for this second amplification. Reactions were purified and concentrated 
by isopropanol precipitation under standard conditions.  
Enzymatic digestions: The double-stranded amplicons were digested using SapI 
(NEB R0569L) according to manufacturer’s protocol in a 150µL reaction containing 30 
µL of enzyme and incubated at 37°C overnight. The products of this reaction were 
concentrated by ethanol precipitation under standard conditions. The resuspended DNA 
was then digested with lambda nuclease (NEB M0262L) at 37°C for 2 hours according 
to manufacturer’s protocol. The products of this reaction were purified using Zymo 
columns with 7X volume binding buffer .  
Streptavidin-biotin purification: Removal of the reverse strand material was 
accomplished using 50 µL of Dynabeads MyOne Streptavidin C1 according to the 
manufacturer’s protocol. Importantly, the unbound supernatant fraction was retained as 
it contains the desired products. The recovered material was precipitated and verified 
using 6% native PAGE stained with SyBr Gold.  
 
Alignment, mapping and counting: 
Reads were sequenced on the NextSeq platform by Cornell Sequencing Center using 
60bp (forward, 5’ end of cDNA) +15bp (reverse, 3’ end of cDNA) paired-end chemistry. 
The adapter sequences were clipped off the reads, and PCR duplicates were removed 
from the dataset by filtering out non-unique reads with respect to all base calls. Reads 
were aligned to the yeast genome (Engel et al. 2014) using the STAR aligner (Dobin et 
al. 2013) using the following alignment parameters: {--alignEndsType EndToEnd --
clip5pNbases 7 0 --alignMatesGapMax 400 --alignSplicedMateMapLmin 16 --
outSAMattributes All --alignSJDBoverhangMin 1 --outSAMmultNmax 1 --
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outSAMunmapped Within KeepPairs --outFilterMismatchNmax 3}. Using a custom 
script, alignments were divided between continuous and gapped alignments via the 
occurrence of an "N" in the cigar string. Alignments crossing an intron and alignments 
crossing a junction were then separately counted on a per target basis using a modified 
version of htseq-count (Anders, Pyl, and Huber 2015). The second read of the paired 
end reads was used to determine the 3' termini of the cDNAs, which we observed to 
often terminate near the TSS, predicted highly structured areas of the RNA, or in the 
case of a lariat-intermediate-derived cDNA, near the branchpoint-A of the intron. To 
make heatmaps and meta-gene plots that quantify the 3' termination of cDNAs around 
these features, we used the deepTools ComputeMatrix command (Ramírez et al. 2016) 
in conjunction with a BigWig coverage file of the 3' terminating bases and bedfiles 
containing TSS-regions and the branchpoint-to-3'ss regions as previously annotated 
(Davis et al. 2000). The heatmaps and metaplots depicting the cumulative distribution 
of 3' termini were made by processing the deepTools computeMatrix output in order to 
successively sum up the counts of 3' termini while moving across the gene feature and 
expressing it as a percent of the total. 
 
Primer sequences used in the experiment: 
Primers were all ordered individually from Integrated DNA Technologies with 
the exception of the pooled oligo mixture, in which case LC Sciences was used.  
Sequence of the reverse transcription primers consists of the following, in order 
from 5’ to 3’ end. The 3’ end of the i5 adapter (after the index) of the Illumina Nextera 
primer sequence (5’TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG 3’), 
followed by 8 random nucleotides used for monitoring PCR artifacts (5’NNNNNNNN 
3’), followed by the gene specific annealing regions as output by OligoWiz (24 – 
26mers).  
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Sequence of the complex pooled oligo mixture consists of the same sequences 
as above, except with the additional of a SapI digestion site (5’CCTCGAAGAGC 3’), 
and addition of a reverse amplification region (5’ATTACGGCTCCTCGCTGCAG 3’).  
Illumina forward primer used to amplify complex mixture of oligo pool: (Biotin 
5’ CTGCAGCGAGGAGCCGTAATGC 3’). 
Reverse primer used to amplify complex mixture of oligo pool: (5’ 3C spacer 
CTGCAGCGAGGAGCCGTAATGC 3’).  
First strand extension primer: (5’ GTCTCGTGGGCTCGGAGATGTGTAT 
AAGAGACAGNNNNNNNNN Hexanediol spacer 3’)  
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Chapter 3: Deciphering a Role for the Chromatin Remodeling Factor Bdf1 in 
pre-mRNA splicing 
3.1: Introduction 
Splicing and transcription are not separate cellular events but are deeply 
interconnected to each other. A variety of experiments over the past several years 
demonstrate that splicing factors are recruited to the nascent RNA co-transcriptionally 
(Bentley DL 2005, Neugebauer KM 2002, Tardiff DF 2006), yet the mechanisms by 
which they are recruited and by which their recruitment facilitates splicing remain 
poorly understood. In order to gain an understanding of the mechanistic details of co-
transcriptional splicing, we set out to identify specific factors that were important for 
functionally coupling these processes together.  
Laura Albulescu, a previous graduate student in the Pleiss lab, began the work 
on this project and had developed a genome-wide screen in S. cerevisiae where splicing 
efficiency was evaluated in the background of ~5500 unique gene mutations, covering 
almost the entire yeast genome. The method Laura developed used quantitative PCR to 
measure expression changes in pre-mRNA levels in the background of the mutants: 
increased levels of pre-mRNA in a strain suggested a defect in splicing, and thus implied 
the corresponding gene plays a role in splicing (Albulescu et al. 2012). The screen not 
only identified an array of known splicing factors, but also identified many candidates 
previously known only for playing roles in chromatin remodeling, transcription, or 3’ 
end processing. One such candidate was Bdf1, a bromodomain containing factor that is 
a component of the transcription factor TFIID and a member of the SWR-C chromatin 
remodeling complex (Durant and Pugh 2006). The Bdf1 protein functions at the 
interface between transcription and chromatin remodeling. As a part of the TFIID 
complex, Bdf1 functions to recruit RNA polymerase II to TATA-less promoters through 
its interaction with Taf7 (Durant and Pugh 2007, Martinez-Campa et al. 2004, 
Pamblanco et al. 2001). In chromatin remodeling, the yeast SWR-C complex is 
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responsible for exchanging histone H2A with histone H2A.Z at promoters genome-wide 
(Krogan et al. 2003, Kobor et al. 2004, Zhang, Roberts, and Cairns 2005). Prior to 
Laura’s work, Bdf1 had not previously been implicated in pre-mRNA splicing, and 
indeed the mechanistic basis for the splicing defect observed in strains lacking Bdf1 is 
unknown.  
Interestingly, Bdf1 has a close homolog Bdf2 which emerged after the whole 
genome duplication event in yeast (Wolfe 2015). Neither protein is essential on their 
own, but they are synthetically lethal when both are deleted. Though most duplicated 
copies of genes from the whole genome duplication event quickly became non-
functional, the fact that both Bdf1 and Bdf2 remained is cause for speculation that they 
acquired diverged functions. When examining the sequence however, the two proteins 
are actually highly similar, with 35% identical and 67% similarity, with both retaining 
two bromodomains and a C-terminal acidic domain. Nevertheless, there are also regions 
of differences between the two proteins where stretches of amino acids are present in 
one protein but not the other and vice versa (Figure 3.1). As the proteins are highly 
similar, it is of no surprise that Bdf2 can interact with Taf7 as well (Matangkasombut 
and Buratowski 2003). There is also evidence to suggest that they can at least have a 
partial overlap in function as Bdf2 is upregulated upon Bdf1 loss and can bind some 
Bdf1 specific promoters (Durant and Pugh 2007).  
 
 - 69 - 
 
Figure 3.1: Bdf1 and Bdf2 are highly similar with stretches of amino acids that are 
different. Gene structures for Bdf1 and Bdf2 shown, with bromodomains highlighted 
in red and acidic domain in black.  
 
Surprisingly, contrary to Bdf1, Bdf2 was not identified as a factor important for 
splicing in our previously mentioned genome-wide screen. Splicing sensitive 
microarrays performed on bdf1Δ confirm that deletion of Bdf1 leads to a global splicing 
defect while bdf2Δ shows normal splicing (Figure 3.2, Albulescu et al. 2012). This 
suggests that even though both proteins are implicated in transcription, only Bdf1 plays 
a role in splicing. This leads to the interesting question of how Bdf1 is involved in pre-
mRNA splicing and what regions have diverged between the two proteins that enable 
this function.  
 
 - 70 - 
 
Figure 3.2: Bdf1 plays a role in splicing while Bdf2 does not. Splicing sensitive 
microarray performed on strains lacking Bdf1 show a marked increase in the pre-
mRNA species whereas strains lacking Bdf2 largely remain unchanged. T P and M 
panels represent Total, pre-mRNA and mature mRNA. Adopted from Albulescu et al. 
2012. 
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As an initial approach to examine this problem, the mechanism by which Bdf1 
impacts splicing was examined. By monitoring U1 snRNP recruitment in the 
background of wildtype, bdf1Δ and bdf2Δ mutants through chromatin 
immunoprecipitation coupled to qPCR (ChIP-qPCR), it was observed that U1 snRNP 
recruitment is diminished upon Bdf1 deletion throughout different genomic regions of 
the ACT1 gene (Figure 3.3A), as well as throughout intronic regions of U3, RPL31B 
and UBC13 (Figure 3.3B). This suggests that the loss of Bdf1 is detrimental to the co-
transcriptional recruitment of U1 snRNP. To have a global look at the genes impacted 
by Bdf1 loss and how it differs from Bdf2 loss, a more comprehensive ChIP-Seq 
experiment will be required.  
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Figure 3.3: Loss of Bdf1 results in a defect in U1 snRNP recruitment as shown by 
ChIP-qPCR. Panel A shows bdf1Δ strain perform worse than both wildtype and bdf2Δ  
when it comes to measuring gDNA signal by qPCR from U1 ChIP throughout the 
actin gene. Panel B shows decreased signal from genomic precursor RNA locations on 
strains with Bdf1 loss as compared to wildtype and Bdf2 loss. 
 
Given the high similarity between Bdf1 and Bdf2 but a lack of role in splicing 
for Bdf2, we hypothesize that Bdf1 and Bdf2 generally share redundant cellular 
functions in transcription, and that Bdf2 can compensate for the transcriptional function 
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of Bdf1 in a bdf1Δ strain. We further hypothesize that Bdf1 has an additional function 
where it also plays a critical role in spliceosomal component recruitment at the start of 
transcription that Bdf2 cannot substitute for. Given its role in transcription, the 5’ biased 
nature of yeast introns (Figure 3.4), combined with the previously mentioned ChIP-
qPCR results, we hypothesize that the spliceosomal component recruited by Bdf1 is the 
U1 snRNP.  
 
Figure 3.4: S cerevisiae introns are 5’ biased. Cumulative distribution plot showing the 
distance of the intron for intron containing genes in S. cerevisiae from the start codon 
to the intron location. 70% of all introns are within 100 basepairs from the start codon. 
 
We present our hypothesis regarding Bdf1 and Bdf2 as the following model. 
Under normal wildtype conditions, Bdf1 is involved in chromatin remodeling, 
transcription initiation, as well as U1 snRNP recruitment (Figure 3.5, top panel). Under 
conditions where Bdf1 is deleted, Bdf2 is regulated and compensates for Bdf1’s 
chromatin remodeling and transcription initiation roles. However, Bdf2 lacks the 
capacity to recruit U1 snRNP, thus resulting in a global splicing defect in bdf1Δ strains 
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(Figure 3.5, bottom panel). This chapter seeks to both identify the genome-wide 
consequences of a loss of Bdf1 on the recruitment of spliceosomal component U1 
snRNP, as well as to identify regions of Bdf1 that are necessary for its interaction with 
U1 snRNP.  
 
 
Figure 3.5: Proposed model for Bdf1’s role in spliceosomal recruitment. Top panel: in 
the presence of Bdf1, U1 snRNP can be recruited co-transcriptionally by Bdf1. 
Bottom panel: Bdf2 is able to compensate the transcriptional role for Bdf1 but unable 
to recruit U1 snRNP, resulting in a global splicing defect. 
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3.2: Materials and methods 
Strains:  
Wildtype strain used is BY4741. 
bdf1Δ and bdf2Δ come from Open Biosystems.  
Mutant strains bdf1* generated by Laura Albulescu, as described by Albulescu 
LO 2012, Ph.D. dissertation.  
Chip-Seq: 
Cell lysis: Started with 300 mL total cells at OD 0.6 per sample. Pellet into a 
screw cap tube and add 500 uL of cold glass beads 0.5mm in diameter to each tube. Add 
1 ml lysis buffer (50 mM Hepes (pH 7.5), 140 mM NaCl, 1 mM EDTA, 1% Triton X-
100, 0.1% NaDeoxycholate, 1 Protease Inhibitor Tablet from Roche) and bead-beat for 
15*2 minutes with 1 minute intervals (for a total of 44 minutes). Puncture the bottom of 
the screw cap tube using a hot 21-gauge needle. Place tube on top of a 5ml syringe barrel 
inside a 15 ml Falcon tube. Centrifuge at 1000*g at 4°C for 1 minute to recover the 
lysed cells. Transfer samples to a new 1.7ml Eppendorf tube. Spin for 15 min at 14K 
rpm and 4°C and discard supernatant. Resuspend samples in 1 mL of Lysis buffer. 
Transfer to 15 mL conical tubes.  
Sonication: Using the Bioruptor sonicator, sonicate at high settings for 20 
seconds with 1 minute off intervals for 25 cycles total. Ensure samples are in ice bath 
as heat can build up from the sonication. Sonication setting can vary, and shearing can 
be easily checked by test samples and gel electrophoresis. Transfer samples into clean 
1.7 mL eppendorf tubes in 100 uL fractions. Spin eppendorf tube for 15 min at 14K rpm 
at 4°C. Transfer supernatant to a new pre-chilled 1.7 mL eppendorf tube and spin for 
another 15 minutes at 14K rpm at 4°C. Transfer supernatant to a new tube. Save a 10ul 
aliquot which will be your 1% Input. Add 90 ul of Elution buffer to the 1% Input and 
flash freeze. Store in the -20C.  
 - 76 - 
Immunoprecipitation: Add Antibody to the samples and rotate at 4°C for 2h. 
Prepare the resin (Protein A/G-agarose, cat #SC-2003 from Santa Cruz), 75 uL of slurry 
for 25 uL of resin for each tube. Washed 3 times with 1 mL Lysis buffer. After each 
wash spin down for 30 sec at 14k rpm in a tabletop microcentrifuge and let settle on ice 
for 1 minute before pippeting the wash buffer off. Keep on ice until use. Right before 
use, resuspend gently by pippeting up and down in lysis buffer of 95 uL per sample. 
Add 95 uL slurry to each tube. Incubate for 2 more hours at 4°C then collect beads by 
spinning for 1 min at 2000 rpm. Remove the rest of the supernatant and wash the beads 
for 15 minutes at 4°C repeated with the following buffers in sequence. 2 washes with 1 
ml Lysis buffer (without protease inhibitors), 2 washes with 1 mL washing buffer (10 
mM TrisHCl (pH 8), 250 mM LiCl, 0.5% NP-40, 0.5% NaDeoxycholate, 1 mM EDTA) 
+360 mM NaCl, 2 washes with 1 mL washing buffer, 2 washes with 1 mL 1X TE buffer. 
Elute in 100 uL elution buffer (50 mM Tris HCl (pH 8), 5 mM EDTA, 1% SDS, 25 mM 
EGTA) and incubate resin for 30 minutes at 65°C with constant tapping every 5 minutes. 
Spin for 5 sec at 14K rpm and transfer supernatant to a new eppendorf tube. This will 
be your IP fraction. Incubate IP and 1% Input tubes overnight at 65°C to reverse 
crosslinking. 
Recovery of DNA fragments: Incubate the overnight samples with 12.5 uL of 
20 mg/ml proteinase K for 2h at 42°C. Use Cycle Pure kit from Omega Bio-Tek by 
following their instructions using the equilibration buffers. Elute in 40 uL. Quantify by 
Qubit using HS dsDNA kit. Standard library prep can then be performed, consisting of 
end repair, A-tailing, adapter ligation, library PCR amplification, size selection and 
sequencing.  
 
Genetics screen: 
Mutant library extraction and cDNA synthesis were done robotically according 
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to Albulescu et al. 2012. Genetics screen by sequencing was done by following the 
protocol from Larson et al. 2016. Data analysis for sequencing starts with reads 
demultiplexed using a combination of Nextera-specific indices and custom plate-
specific barcodes (Mamanova et al. 2010) within the insert read. The bwa-mem aligner 
(Li and Durbin 2009) was then used to align reads to a custom index containing both 
the spliced and unspliced isoforms of the target U3 gene. Alignments were then reported 
as counts with respect to plate and well numbers for the bdf1* mutants.  
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3.3: Results and Discussion 
3.3.1: ChIP-Seq of Bdf1 mutants 
Preliminary ChIP-qPCR data suggested that U1 snRNP recruitment was 
diminished upon Bdf1 deletion throughout different genomic regions of the ACT1 gene, 
as well as throughout intronic regions of U3, RPL31B and UBC13 (Albulescu et al. 
2012). In order to assess whether this is a genome-wide phenomenon, we performed 
ChIP-Seq on wildtype, bdf1Δ and bdf2Δ strains where the Yhc1 (U1C) gene of U1 
snRNP was Tap-tagged to test for co-transcriptional U1 occupancy (see methods). As a 
control for data quality, we also immunoprecipitated against Rpb3, an RNA polymerase 
II subunit. We found that on average, in all 3 strains, U1 was immunoprecipitated and 
peaks at ~500bp downstream of the transcription start site (TSS) for intron containing 
genes. What is unclear is how the 3 different strains differ in degree in their ability in 
U1 snRNP recruitment. According to previously presented ChIP-qPCR data, wildtype 
and bdf2Δ strains should be equal in their ability to recruit U1 snRNP while bdf1Δ 
strains would perform significantly worse. Based on the data we obtained, bdf1Δ is 
apparently worse at U1 snRNP recruitment than wildtype, which is consistent with 
previously mentioned ChIP-qPCR result. However, bdf2Δ appears to have an even 
stronger defect in recruiting U1 snRNP, which contradicts with previously presented 
data that its deletion did not result in a splicing defect, and that it should have no effect 
on U1 snRNP recruitment (Figure 3.5).  
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Figure 3.5: ChIP-Seq of U1C is apparently inconsistent with previously published 
ChIP-qPCR data. U1C ChIP-Seq shows less U1C pull down from bdf1Δ than 
wildtype, but more than that of bdf2Δ. Position 0 is aligned to the transcription start 
site. 
 
To examine this discrepancy with previously published data, we look to 
eliminate the possibility that the conflicting answer we obtained is due to poor 
normalization. Upon observation of the ChIP-Seq profile for Rpb3, we see that RNA 
polymerase II pull down is not equally distributed in signal intensity even after 
correcting for sequencing depth. In the bdf2Δ strain, an apparent higher signal among 
gene bodies suggested more Rpb3 was pulled down than in the bdf1Δ strain, both of 
which have lower signal than wildtype (Figure 3.6). Taken at face value, if we assume 
Rpb3 pull down data can be used to normalize for the amount of pull down in U1 
snRNP, we actually end up with an even lowered U1 snRNP pull down profile in bdf2Δ 
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as compared with either wildtype or bdf1Δ, making the observed discrepancy gap 
between ChIP-Seq and ChIP-qPCR wider, and not narrower.  
 
Figure 3.6: RNA Polymerase II ChIP-Seq data show the three strains, wildtype, bdf1Δ 
and bdf2Δ, pull down Rpb3 at unequal levels throughout intron containing genes. 
Position 0 is aligned to the transcription start site. 
 
Due to the noisy nature of antibody binding, normalization for the comparison 
of data between different ChIP-Seq experiments is difficult. It is widely known that 
uniform genome-wide occupancy increases or decreases can be missed (Bonhoure et al. 
2014). Relative peak height, even though corrected to read depth, can still be misleading 
as there is no way to control for differences in antibody binding due to the different 
mutants used in different experiments.  
In order to overcome this difficulty, a better normalization method is required. 
Such a method would need be able to perform cross sample comparisons of occupancy 
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levels for a set of loci of interest. Unless normalization methods that attempt to fix 
experimental variation after sequencing, this method would be performed before 
precipitation so that experimental noise is carried throughout the process. One such 
method, spike adjustment procedure (SAP), consists of an additional step prior to 
immunoprecipitation where a constant, low amount of a single batch of chromatin from 
a foreign organism is added to all experimental samples as an internal control (Bonhoure 
et al. 2014). This method will allow the adjustment of each experiment to the internal 
control and thus making their occupancy directly comparable to each other.  
As a logical next step of the experiment, we have already obtained a S. pombe 
Chp1-Tap tagged strain (Verdel 2004 et al.) to be used for normalization. We should 
then repeat the previously described ChIP-Seq experiments with small amounts of S. 
pombe chromatin present, normalize all datasets to the internal S. pombe chromatin 
control, then be able to observe whether bdf1Δ does fail globally in recruiting U1 
snRNP.  
 
3.3.2 Forward genetics screen of Bdf1 mutants 
In order to decipher which part of the Bdf1 protein interacts with U1 snRNP, we 
made use of a library of ~1500 mutant strains of bdf1*, where * denotes a different 
mutant in Bdf1, and screened the library for mutants which behaved like bdf1Δ. The 
library was prepared by Laura Albulescu during her work as a graduate student in the 
Pleiss lab (Albulescu LO, 2013 Ph.D. dissertation). Summarized briefly, the open 
reading frame of Bdf1 was mutagenized using Mutazyme II technology, where an 
average of 3-9 single nucleotide mutations had been introduced into each mutant ORF, 
those were then placed into a plasmid surrounded by the native Bdf1 genomic UTRs. 
This plasmid was then placed into a strain where genomic BDF1 and BDF2 were 
deleted, and a URA marked plasmid copy of Bdf2 was shuffled out on 5-FOA. This 
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method ensured that the only functional Bdf copy in the cell would be from bdf1*. The 
mutants of this library were individually arrayed in 384 well plates for easier subsequent 
manipulation with robotics.  
To test the library of bdf1* for mutants that behaved like bdf1Δ, we employed a 
sequencing based genetics screen developed by Amy Larson and Benjamin Fair (Larson 
et al. 2016). Briefly summarized, U3 precursor mRNA levels were used as a proxy for 
splicing efficiency, where an increased precursor level indicated a failure in the splicing 
pathway. With the aid of robotics, the ~1500 bdf1* mutant library were grown in YPD 
under normal conditions, then had RNA extracted and reverse transcription performed 
to synthesize cDNAs using random primers. Inward facing primers containing 
sequencing amplifiable overhangs annealed to regions in exon 1 and exon 2 of U3 
respectively were designed and used to amplify cDNAs synthesized from both the 
mature mRNA as well as the pre-mRNA. Custom barcoded PCR amplifications were 
then performed so each mutant would have a uniquely identifiable barcode. The 
sequencing library was then pooled and sequenced by Illumina Nextseq (Figure 3.7, 
modified from Larson et al. 2016).  
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Figure 3.7: Schematic showing the forward genetics screen for bdf1*. The mutants are 
on arrayed on multiple 384 well plates, and RNA can be robotically extracted and 
reverse transcribed into cDNA. Multiple rounds of PCRs are then performed to append 
barcodes and the library is then pooled and sequenced. Modified from Larson et al. 
2016 
 
The reads from sequencing are splicing informative because they will either read 
into the intron-exon boundary, indicating the presence of a pre-mRNA, or read into the 
exon-exon boundary, indicating the mature species. We can use this information to 
calculate splice indices for each mutant and find bdf1* mutants that have a high fraction 
of precursor U3 mRNA, indicative of a defect in splicing.  
Previously published qPCR results indicate that U3 has a splice efficiency of 
~97.5% (Pleiss et al. 2007), and so we designed a sequencing experiment for which each 
mutant strain was sampled with ~10,000 total reads, a level of sequencing high enough 
that even the unspliced species should be sampled at high enough read depth to provide 
reproducible values. To our surprise and disappointment, when considering the 
combined data from the ~1500 mutant strains of this experiment, a total of ~15 million 
reads were obtained that map to the mature species of U3 mRNA, whereas fewer than 
~1500 reads were obtained that map to the precursor U3 mRNA. This paucity of 
unspliced reads was not only inconsistent with our expectations for the level of U3 pre-
mRNA that would be present in the cell, but was also so low as to preclude any 
meaningful calculations of changes in relative splicing efficiency for any of the mutant 
samples.  
We hypothesize the discrepancy in pre-mRNA detection comes from the 
inability of reverse transcriptase to make a full-length cDNA copy of the U3 pre-mRNA, 
possibly due to intronic structures that would preclude reverse transcriptase activity. 
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Whereas in qPCR, U3 pre-mRNA levels were measured by using primer pairs that 
reside at the 3’ end of the intron and beginning of exon 2 respectively, with only a few 
basepairs between them, the primers in the previously designed sequencing experiment 
would require the entire length of the intron present to be able to amplify the full pre-
mRNA sequence.  
To test this hypothesis, saturating PCR was performed on the bdf1* strain using 
the primer pair from the screen and analyzed by gel electrophoresis. The expected 
product size for the mature mRNA is 163 basepairs and the expected product size for 
the pre-mRNA is 320 basepairs. As is evident from the gel image, no pre-mRNA 
product is detectable, in spite the robust detection of the mature mRNA, and in line with 
our hypothesis (Figure 3.8).  
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Figure 3.8: No expected product size observed for the pre-mRNA of bdf1* mutants 
using exon flanking primers. 6% PAGE showing the product of saturating PCR on 
bdf1* mutants next to 100 basepair ladder. Expected size of mature mRNA is 163 
basepairs and pre-mRNA is 320 basepairs. Only the mature mRNA is observed in 
bdf1* strains. 
 
To circumvent this problem, we plan to modify the screen protocol in a way that 
does not require the full-length cDNA to be made for it to be amplifiable. Instead of 
amplifying the cDNA product directly, we will incorporate the first strand extension 
strategy employed in chapter 2 of this dissertation, namely using an Illumina Nextera 
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sequence containing, randomer primed, 3’ end blocked oligo in conjunction with 
Klenow to append the Illumina Nextera sequence onto the end of the newly synthesized 
cDNA. This will allow the amplification of any length cDNA products produced with a 
combination of the exon 2 U3 primer and a forward Illumina primer, even those that do 
not contain the full-length pre-mRNA. To prevent amplification of excess extension 
primers, blocked sequences complementary to the extension primer can be added in 
excess after the extension reaction, which will effectively remove the pool from being 
amplifiable, a strategy employed in the QuantSeq library preparation method (Moll et 
al. 2014).  
Repeating the screen with the above-mentioned modifications should allow us 
to gain useful information on bdf1* mutant phenotypes, and identify those mutants that 
phenocopy bdf1Δ strains. Once identified, we can identify the locations of the mutations 
within those mutant strains by sanger sequencing, and therefore find out which part of 
the protein is necessary for U1 recruitment.  
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Future Directions 
 
Splice-Seq:  
The development of the Splice-Seq technique should be further applied to higher 
systems with more complex intronomes. A natural next step is to attempt this in S. 
pombe, which has ~5000 introns compared with the ~300 in S. cerevisiae. A complex 
pool of primers targeting those ~5000 introns were ordered and amplified as described 
in Chapter 2 for S. pombe and Splice-Seq libraries were made using those primers. The 
overall mapping data for the preliminary Splice-Seq run in S. pombe is shown in figure 
S1.  
 
Figure S1: Preliminary mapping statistics of Splice-Seq in S. pombe.  
 
As is evident from Figure S1, the overall read mapping distribution appears to 
have a larger fraction of both unmappable reads as well as unextended primers when 
compared to the mapping statistics of S. cerevisiae, shown in Figure 2.1B. Importantly, 
despite the increase in the number of unextended primers and off-target reads, there is 
still 5% of reads that are on-target and splicing informative, which is what we would 
have expected them to be in the first place. One such example is shown for the multi-
5%
0%
46%
49%
S. pombe
On-target, splicing
informative reads
Off target reads
Unextended primers
Unmappable reads
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intronic rpl22 gene in figure S2.  
 
Figure S2: Splice-Seq mapping coverage for rpl22 in S. pombe. Green 
indicates mapped reads, red arc denotes mature reads (reads that map across exons).   
 
I hypothesize that the increase in off-target reads when compared to S. cerevisiae 
is due to the increased complexity of the S. pombe intronome. To circumvent this 
problem, I propose several potential fixes. The first of which is to decrease mis-
annealing events by raising the temperature and make use of a thermostable reverse 
transcriptase in the RT reaction instead of the MMLV enzyme used in the current 
method. Commercial thermostable reverse transcriptase enzymes have been previously 
tested in our lab (ThermoScript, Invitrogen 12236-014) to be able to synthesize cDNA 
at well beyond the average annealing temperatures of ~55°C (up to 65°C has been 
tested, unpublished data) for which the pool of gene specific reverse transcription 
primers were designed for. The increase in temperature should decrease the amount of 
mis-priming and decrease the fraction of reads that are off-target or unmapped due to 
having too many mismatches because of mis-priming. In order to combat the increased 
complexity of the reverse transcription reaction and make the substrates easier to find 
each other, the input RNA used for Splice-Seq in S. pombe can also be fragmented 
instead of using intact total RNA as in the case of the current method. Fragmenting the 
RNA will in theory allow the targets to flow better and find the targets easier. To 
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decrease the amount of background priming, it is also worth trying to use selected RNA 
as the input to Splice-Seq libraries instead of total RNA. Either poly-A selection or ribo-
depletion will enable significantly reduced background levels at the cDNA synthesis 
stage.  
In addition to optimizing Splice-Seq in higher systems, more work can be done 
in S. cerevisiae to further our understanding of the rates of splicing. Coupled with 
metabolic labeling where nascent RNA can be obtained through a time dependent 
manner, both the overall rate of splicing, as measured by the change in the amount of 
intronic reads and mature reads over time, as well as the rates of splicing for each of the 
two chemical steps of splicing, as measured by the change in the amount of totally 
unspliced pre-mRNA reads, lariat intermediate reads and mature mRNA reads over 
time, can be obtained by plotting that change over time. Preliminary work is already 
underway in this area, and we hope that by doping in a small amount of control to 
normalize the samples across different time points, we will soon be able to calculate 
absolute rates of splicing with the help of Splice-Seq.  
 
BDF1:  
To gain a further understanding of what is the unique role that Bdf1 plays in 
splicing in addition to its roles in transcription, I would like to identify a mutant in Bdf1 
that phenocopies bdf1Δ strain. Repeating the screen to the library of mutants that Laura 
had prepared using the modifications mentioned in Chapter 3 should allow me to 
identify such a mutant, and subsequent identification of the mutation will allow insight 
into which region of the Bdf1 protein is important for such an interaction.  
To assess how Bdf1 affects spliceosomal recruitment, further ChIP-Seq 
experiments will also be carried out. As described in Chapter 3, in order to perform a 
good ChIP-Seq experiment, proper normalizations with a foreign DNA sample input is 
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required and will allow the direct comparison between samples, and allow for 
assessment of different U1 binding profiles in mutants of bdf1.  
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